Citadel Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Buy |
+10,114
| New | +$114K | ﹤0.01% | 5227 |
|
|
2025
Q1 | – | Sell |
-141,735
| Closed | -$1.39M | – | 6143 |
|
|
2024
Q4 | $1.39M | Buy |
+141,735
| New | +$1.39M | ﹤0.01% | 2975 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5963 |
|
|
2024
Q2 | – | Sell |
-113,226
| Closed | -$5.25M | – | 6083 |
|
|
2024
Q1 | $5.25M | Buy |
113,226
+42,852
| +61% | +$1.99M | ﹤0.01% | 1727 |
|
|
2023
Q4 | $4.76M | Sell |
70,374
-60,707
| -46% | -$4.1M | ﹤0.01% | 1686 |
|
|
2023
Q3 | $9.49M | Buy |
131,081
+105,249
| +407% | +$7.62M | ﹤0.01% | 1191 |
|
|
2023
Q2 | $1.92M | Buy |
25,832
+2,872
| +13% | +$214K | ﹤0.01% | 2452 |
|
|
2023
Q1 | $1.22M | Buy |
22,960
+19,891
| +648% | +$1.06M | ﹤0.01% | 2991 |
|
|
2022
Q4 | $207K | Sell |
3,069
-375
| -11% | -$25.3K | ﹤0.01% | 4669 |
|
|
2022
Q3 | $430K | Sell |
3,444
-59,596
| -95% | -$7.44M | ﹤0.01% | 4233 |
|
|
2022
Q2 | $6M | Buy |
63,040
+62,170
| +7,146% | +$5.92M | ﹤0.01% | 1698 |
|
|
2022
Q1 | $141K | Sell |
870
-15,413
| -95% | -$2.5M | ﹤0.01% | 5485 |
|
|
2021
Q4 | $5.41M | Sell |
16,283
-9,775
| -38% | -$3.25M | ﹤0.01% | 2035 |
|
|
2021
Q3 | $12M | Buy |
+26,058
| New | +$12M | ﹤0.01% | 1277 |
|